[go: up one dir, main page]

NO20014221L - Fremgangsmåte for behandling av anstrengelses-indusert astma - Google Patents

Fremgangsmåte for behandling av anstrengelses-indusert astma

Info

Publication number
NO20014221L
NO20014221L NO20014221A NO20014221A NO20014221L NO 20014221 L NO20014221 L NO 20014221L NO 20014221 A NO20014221 A NO 20014221A NO 20014221 A NO20014221 A NO 20014221A NO 20014221 L NO20014221 L NO 20014221L
Authority
NO
Norway
Prior art keywords
exertion
treating
induced asthma
asthma
induced
Prior art date
Application number
NO20014221A
Other languages
English (en)
Norwegian (no)
Other versions
NO20014221D0 (no
Inventor
Richard Nieman
Theodore Torphy
Siegfried Christensen
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO20014221D0 publication Critical patent/NO20014221D0/no
Publication of NO20014221L publication Critical patent/NO20014221L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20014221A 1999-03-01 2001-08-31 Fremgangsmåte for behandling av anstrengelses-indusert astma NO20014221L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12246499P 1999-03-01 1999-03-01
US14129199P 1999-06-28 1999-06-28
PCT/US2000/005363 WO2000051599A1 (fr) 1999-03-01 2000-03-01 Methode de traitement de l'asthme provoque par l'effort

Publications (2)

Publication Number Publication Date
NO20014221D0 NO20014221D0 (no) 2001-08-31
NO20014221L true NO20014221L (no) 2001-10-24

Family

ID=26820540

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014221A NO20014221L (no) 1999-03-01 2001-08-31 Fremgangsmåte for behandling av anstrengelses-indusert astma

Country Status (19)

Country Link
US (1) US6555576B1 (fr)
EP (1) EP1156800A4 (fr)
JP (1) JP2002538115A (fr)
KR (1) KR20010102460A (fr)
CN (1) CN1350453A (fr)
AR (1) AR035987A1 (fr)
AU (1) AU3715000A (fr)
BR (1) BR0008625A (fr)
CA (1) CA2366041A1 (fr)
CO (1) CO5150236A1 (fr)
CZ (1) CZ20013148A3 (fr)
HK (1) HK1043727A1 (fr)
HU (1) HUP0200026A3 (fr)
IL (1) IL144996A0 (fr)
NO (1) NO20014221L (fr)
NZ (1) NZ513697A (fr)
PL (1) PL352822A1 (fr)
TR (1) TR200102515T2 (fr)
WO (1) WO2000051599A1 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY121142A (en) * 1999-02-23 2005-12-30 Smithkline Beecham Corp Controlled release formulation for treating copd
EA200200502A1 (ru) * 1999-10-29 2002-10-31 Смитклайн Бичам Корпорейшн Способ введения ингибитора фосфодиэстеразы 4
GB0103630D0 (en) 2001-02-14 2001-03-28 Glaxo Group Ltd Chemical compounds
BRPI0212455B8 (pt) 2001-09-14 2021-05-25 Glaxo Group Ltd composto derivado de fenetanolamina para o tratamento de doenças respiratórias, formulação farmacêutica, combinação, e, uso do mesmo
GB0201677D0 (en) 2002-01-25 2002-03-13 Glaxo Group Ltd Medicament dispenser
RU2332400C2 (ru) 2002-10-28 2008-08-27 Глаксо Груп Лимитед Производные фенэтаноламина для лечения респираторных заболеваний
GB0303396D0 (en) 2003-02-14 2003-03-19 Glaxo Group Ltd Medicinal compounds
JPWO2004087147A1 (ja) * 2003-03-31 2006-06-29 協和醗酵工業株式会社 肺疾患の治療および／または予防剤
GB0317374D0 (en) 2003-07-24 2003-08-27 Glaxo Group Ltd Medicament dispenser
EP1699436A2 (fr) * 2003-12-12 2006-09-13 Myogen, Inc. Preparations a base d'enoximone et leur utilisation pour traiter l'hypertrophie cardiaque et l'insuffisance cardiaque
WO2005092333A1 (fr) * 2004-03-22 2005-10-06 Myogen, Inc. (r)-enoximone sulfoxyde et son utilisation dans le traitement de maladies induites par pde-iii
JP2007530563A (ja) * 2004-03-22 2007-11-01 ミオゲン インコーポレイティッド （ｓ）−エノキシモンスルホキシドおよびｐｄｅ−ｉｉｉ媒介疾患の治療におけるその使用
WO2006007213A1 (fr) * 2004-06-23 2006-01-19 Myogen, Inc. Formulations d'enoximone et utilisation dans le traitement de maladies a mediation par pde-iii
GB0418278D0 (en) 2004-08-16 2004-09-15 Glaxo Group Ltd Medicament dispenser
PE20100737A1 (es) 2005-03-25 2010-11-27 Glaxo Group Ltd Nuevos compuestos
GB0515584D0 (en) 2005-07-28 2005-09-07 Glaxo Group Ltd Medicament dispenser
GB0525337D0 (en) * 2005-12-13 2006-01-18 Novartis Ag Organic compounds
GB0622827D0 (en) 2006-11-15 2006-12-27 Glaxo Group Ltd Sheet driver for use in a drug dispenser
US20090209488A1 (en) * 2008-02-19 2009-08-20 Roger Wayne Brown Compositions for the treatment of exercise induced asthma
US20190307975A1 (en) 2016-11-21 2019-10-10 Lupin Inc. Medicament dispenser
US20210085897A1 (en) 2018-04-06 2021-03-25 Lupin Inc. Medicament dispenser
WO2020058823A1 (fr) 2018-09-17 2020-03-26 Lupin, Inc. Ensemble indicateur de dose pour distributeur de médicaments
EP4126139A1 (fr) 2020-03-25 2023-02-08 Lupin Inc. Distributeurs de médicaments à plusieurs supports
CN116210004A (zh) 2020-07-23 2023-06-02 鲁平股份有限公司 用于药剂分配器的剂量计数器组件

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9301943A (es) 1992-04-02 1994-08-31 Smithkline Beecham Corp Compuestos.

Also Published As

Publication number Publication date
KR20010102460A (ko) 2001-11-15
CA2366041A1 (fr) 2000-09-08
JP2002538115A (ja) 2002-11-12
EP1156800A1 (fr) 2001-11-28
IL144996A0 (en) 2002-06-30
BR0008625A (pt) 2002-02-19
AU3715000A (en) 2000-09-21
WO2000051599A1 (fr) 2000-09-08
PL352822A1 (en) 2003-09-08
EP1156800A4 (fr) 2004-11-24
CN1350453A (zh) 2002-05-22
NO20014221D0 (no) 2001-08-31
TR200102515T2 (tr) 2002-04-22
HUP0200026A2 (hu) 2002-05-29
CO5150236A1 (es) 2002-04-29
AR035987A1 (es) 2004-08-04
NZ513697A (en) 2001-09-28
HK1043727A1 (zh) 2002-09-27
HUP0200026A3 (en) 2003-03-28
CZ20013148A3 (cs) 2002-08-14
US6555576B1 (en) 2003-04-29

Similar Documents

Publication Publication Date Title
NO20014221L (no) Fremgangsmåte for behandling av anstrengelses-indusert astma
DE69516866D1 (de) Stereochemische wortmanninderivate
DK1076657T3 (da) Hidtil ukendte hydroxyindoler, deres anvendelse som inhibitorer for phosphodiesterase 4 og fremgangsmåde til deres fremstilling
DE69831937D1 (de) Bicyclische protein-farnesyl-transferase inhibitoren
AP1699A (en) New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
EA200001102A1 (ru) Способ синтеза ингибиторов сох-2 (циклооксигеназы-2)
BG101712A (en) Method for cathepsin k inhibition
WO1999005096A3 (fr) Inhibiteurs d'urokinase
EA200001129A3 (ru) Способ получения 4-карбоксиамино-2-замещенного-1,2,3,4-тетрагидрохинолина
EP1405048A4 (fr) Procede et appareil pour suivre une partition de musique
WO2002030353A3 (fr) INHIBITEURS DU NF-λB
ATE250077T1 (de) Steroid sulfataseinhibitoren, verfahren zu ihrer herstellung und verwendung
AU2002331627A1 (en) Apparatus and method for pre-treatment of wood chips
AU2001260880A1 (en) Pharmaceutical compounds for treating copd
BR9808923B1 (pt) processos para fazer compostos inibidores de ciclooxigenase-2, e, compostos intermediÁrios para fazer inibidores de ciclooxigenase-2.
AU2001268233A1 (en) Compositions and methods for treating neoplastic disease using inhibitors of laminin5beta3
NO20051146L (no) Fremgangsmate for fremstilling av mellomprodukter nyttige for fremstilling av tubulininhibitorer
NO20014222L (no) Fremgangsmåte for behandling av COPD
NO20015896D0 (no) Fremgangsmåte for å belegge partikler og partikler produsert ved denne
EP1385993B8 (fr) Procede de detection et de traitement de pathologies associees au syndrome de la sclerose tubereuse
PL330227A1 (en) Method of obtaining phenylheterocyclic compounds suitable as cox-2 inhibitors
ATE319689T1 (de) Naphthamidin-urokinasinhibitoren
PT1019347E (pt) Metodo para a sintese de taxanos
EP0954313A4 (fr) Procede de traitement de tumeurs ayant des besoins eleves en lipoproteine de basse densite (ldl) a l'aide d'inhibiteurs de la proteine microsomale de transfert des triglycerides (mtp)
AU5258701A (en) Method of searching for arteriosclerosis inhibitors and shrinkers

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application